Neuroptis announced positive results from a second animal trial of its preservative-free ML7 eye drops. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye syndrome. Both animal trials demonstrated excellent local tolerance and very low systemic absorption. In the more
To use all functions of this page, please activate cookies in your browser.